GENIE : Genome engineering in epigenetics
The “Genome ENgeneering In Epigenetics” (GENIE) platform focuses on the various applications of CRISPR/Cas technologies in the field of epigenetics.
CRISPR/Cas-based applications for epigenetic studies
Presentation
GENIE assists researchers in the planning of experiments and the assembly of reagents for the generation of custom experimental systems. We provide expertise and tools for various genome and epigenome engineering applications.
Our goal is to facilitate the choice of genome editing, epigenome and other tools based on CRISPR/Cas technologies. GENIE is open to all members of the UMR7216 Epigenetics and Cell Fate unit and to a certain extent to members of the transverse programs of the Labex “Who am I?”. The acceptance of external projects is possible after discussion with the steering committee and depends on the resources available.
Expertise
Our expertise lies in the following areas:
- Genome editing: knock-out, knock-in, and point mutation introduction
- Modulation of gene expression and modification of the epigenome
- Use of CRISPR/Cas technologies for imaging or for identification of protein composition of the locus of interest using proximity tagging techniques
- CRISPR/Cas targeting of RNA for degradation, imaging, or editing
Services
- Access to the bank of molecular tools for genome engineering, epigenomes and RNA modifications.
- Protocols, advice, and technical support for genome and epigenome engineering and other applications based on CRISPR/Cas technologies.
- Implementations of novel CRISPR/Cas-based approaches adapted to the needs of the unit.
- Training for new users in CRISPR-based technologies in a form of a course on genome and epigenome editing.
In collaboration with other platforms of the unit, GENIE assists in determining the optimal guide sequences and/or recombination template and in designing the optimal engineering strategy for each project, with an emphasis on easy downstream screening. We also help to choose the best way to deliver components for (epi)gene editing into cells. Besides the classical transfection reagents or nucleofection available in the EDC teams, full support can be provided for lentiviral delivery systems in collaboration with Vectorology platform.
Members
Resources
Bank of molecular tools for genome and epigenome engineering
To get access to GENIE’s bank of vectors, contact us
Contact
GENIE
Lamarck B building, room 411
35 rue Hélène Brion, 75013 Paris
e-mail: genie@parisepigenetics.com
Steering committee
Joined steering committee for GENIE and Vectorology platforms:
-
- Slimane Ait-Si-Ali
- Pierre-Antoine Defossez
- Aurélie de Thonel
- Ekaterina Boyarchuk (Vectorology & GENIE platforms manager)
Read more
Seminar Anne-Sophie Lebre– May 27, 2026
Pr. Anne-Sophie Lebre CHU de Reims - Hôpital Robert Debré, France Invited by Pr. Bertrand Cosson "Brain (epi)genome study in CNS rare disorders" The seminar will take place in the Institut Jacques Monod seminar room (RB-18B). Bâtiment Buffon, 15 rue Hélène Brion,...
Seminar Hiroshi Kimura– May 20, 2026
Dr. Hiroshi Kimura Institute of Quantitative Biosciences, University of Tokyo, Japan Invited by Dr. Pierre-Antoine Defossez "Dynamics of chromatin modification and transcription in vivo." The seminar is Zoom-only On Wednesday, May 20that 11:00 am....
Bing Zhu Seminar – May 6, 2026
Dr. Bing Zhu Institute of Biophysics, Chinese Academy of Sciences, Beijing, China Invited by Dr. Pierre-Antoine Defossez "Epigenetics: remember the past & prepare for the future." The seminar is Zoom-only On Wednesday, May 6that 11:00 am....
Harm H. Kampinga Seminar – April 15, 2026
Dr. Harm H. Kampinga Dept. Biomedical Sciences, UMCG/RuG, Groningen, The Netherlands Invited by Dr. Valérie Mezger "Collapse of protein homeostasis as driver of age-related protein aggregation diseases" The seminar will take place in the Institut Jacques Monod seminar...